Figure 2

Figure 2

Waterfall plot showing percent change from baseline in total polyp burden at Week 25 for efficacy-evaluable patients receiving REC-4881 (4 mg QD)

Format

JPEG

Source

Recursion Pharmaceuticals, Inc.

Téléchargements